KRAS and lung cancer: Moreover, TUBB6 is strongly associated with TUBA1B, inhibits PRKACA and expresses differential regulation on KRAS (activation in case of adenocarcinoma and inhibition in case of SQCC) thus emphasizing the importance of the regulation changes in tubulin-beta for distinguishing the two types of lung cancer.